Skip to content

Author

O. Gonçalves

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Edaravone dexborneol for acute ischaemic stroke among patients undergoing endovascular treatment: a systematic review and meta-analysis.

BACKGROUND Acute ischaemic stroke (AIS) remains a major cause of disability and mortality worldwide. Endovascular treatment (EVT) is the standard of care for large vessel occlusion, yet a favourable neurological outcome is not achieved in all patients. Edaravone dexborneol (ED) has been proposed as an adjuvant therapy...

P. Łajczak, Luiz Henrique Alves Nogueira, J. V. Andrade Fernandes et al. · 0 citations
Open access Sep 2026

A proposal for the classification of early complications during percutaneous central venous access: previous note

Abstract Central venous access is a common hospital procedure that plays an essential role in many clinical situations. Despite its widespread use, there is no standardized classification for early complications, which limits systematic analysis and development of health indicators. This study aimed to propose an objec...

Moura Campêlo José da Cruz, L. Reinaldo, Alexandre da Costa Machado Matos Terceiro et al. · 0 citations
Review Open access Oct 2026

Efficacy and safety of tavapadon for Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials

The therapeutic potential of selective D1/D5 receptor agonism as an effective strategy to enhance motor function in patients with Parkinson’s disease is supported and the need to balance efficacy with tolerability in clinical decision-making is highlighted.

Théo Santana Campos, Pedro Sandes Pereira, Guilherme Garcia Nery et al. · 0 citations
Review Open access Sep 2026

Short-term efficacy and safety of tavapadon for Parkinson's disease: An exploratory systematic review and meta-analysis of randomized clinical trials.

BACKGROUND AND OBJECTIVES Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss and motor and non-motor impairment. Current therapies are limited by motor complications and adverse effects. Tavapadon, a selective dopamine D1/D5 receptor partial agonist, has emerg...

Théo Santana Campos, Pedro Sandes Pereira, Maria Eduarda Pires Marques et al. · 0 citations
Review Open access Sep 2026

DWI-FLAIR mismatch versus perfusion-based selection for extended window thrombolysis in acute ischemic stroke: a meta-analysis of randomized controlled trials.

No definitive superiority or equivalence was established between imaging strategies; imaging choice should be guided by clinical context, time window, EVT eligibility, local workflow, and patient-level factors.

Jagkirat Singh, Victor Hugo Pinheiro Lopes, Marianna Leite et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.